Literature DB >> 8352730

The role of the 5'-flanking region in the cell-specific transcription of the human von Willebrand factor gene.

V Ferreira1, Z Assouline, J L Schwachtgen, B R Bahnak, D Meyer, D Kerbiriou-Nabias.   

Abstract

Transcriptional regulation of the human von Willebrand factor (vWF) gene was investigated in calf pulmonary artery endothelial (CPAE), HeLa, COS 7 and Hep G2 cells. Various lengths of flanking sequences extending up to 2123 bp 5' of the transcription initiation site and containing 19 bp of the first exon, were linked to the bacterial chloramphenicol acetyltransferase (CAT) gene and these constructs were assayed in transient transfection assays. Sequences up to 89 bp upstream of the cap site showed transcriptional activity in all cell types. Sequences between -147 and -419 bp markedly reduced CAT activity in CPAE cells and abolished it in other cell lines. A domain from -592 to -810 bp generated low levels of expression only in CPAE cells. This transcriptional activity was repressed with constructs containing 1041 to 1240 bp upstream of the cap site. Endothelial cell-specific transcription was restored by a construct that contained 1286 bp upstream of the cap site. The additional 46 bp upstream of the negative regulatory domain were within the 5' end of an inverse human Alu-family DNA repeat. RNAase-protection assays confirmed the correct transcriptional initiation. The sequence between -89 and -420 contained at least one negative regulatory element able to repress the CAT gene expression controlled by the heterologous thymidine kinase promoter in all cell types. A construct that included the sequence from -89 to -1286 bp increased the transcriptional activity directed by the thymidine kinase promoter only in CPAE cells. These results indicate that negative and positive elements in the 5'-flanking region interact to regulate vWF gene expression.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8352730      PMCID: PMC1134414          DOI: 10.1042/bj2930641

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  37 in total

1.  The human von Willebrand factor gene. Structure of the 5' region.

Authors:  D Bonthron; S H Orkin
Journal:  Eur J Biochem       Date:  1988-01-15

2.  Mediation of fibrin-induced release of von Willebrand factor from cultured endothelial cells by the fibrin beta chain.

Authors:  J A Ribes; F Ni; D D Wagner; C W Francis
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

3.  Plasmid vectors with multiple cloning sites and cat-reporter gene for promoter cloning and analysis in animal cells.

Authors:  T Frebourg; O Brison
Journal:  Gene       Date:  1988-05-30       Impact factor: 3.688

4.  Expression of von Willebrand factor in porcine vessels: heterogeneity at the level of von Willebrand factor mRNA.

Authors:  B R Bahnak; Q Y Wu; L Coulombel; Z Assouline; D Kerbiriou-Nabias; G Piétu; L Drouet; J P Caen; D Meyer
Journal:  J Cell Physiol       Date:  1989-02       Impact factor: 6.384

Review 5.  von Willebrand factor and platelet function.

Authors:  D Baruch; B Bahnak; J P Girma; D Meyer
Journal:  Baillieres Clin Haematol       Date:  1989-07

6.  Basal expression of the histone H5 gene is controlled by positive and negative cis-acting sequences.

Authors:  S Rousseau; J Renaud; A Ruiz-Carrillo
Journal:  Nucleic Acids Res       Date:  1989-09-25       Impact factor: 16.971

7.  Proteolytic and immunologic comparison of human and bovine von Willebrand factor.

Authors:  M R Bakhshi; E P Kirby
Journal:  Thromb Haemost       Date:  1990-06-28       Impact factor: 5.249

8.  Transcription and replication silencer element is present within conserved region of human Alu repeats interacting with nuclear protein.

Authors:  N V Tomilin; S M Iguchi-Ariga; H Ariga
Journal:  FEBS Lett       Date:  1990-04-09       Impact factor: 4.124

9.  Synthesis of antihemophilic factor antigen by cultured human endothelial cells.

Authors:  E A Jaffe; L W Hoyer; R L Nachman
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

10.  Perturbation of cultured human vascular endothelial cells by phorbol ester or thrombin alters the cellular von Willebrand factor distribution.

Authors:  J H Reinders; R C Vervoorn; C L Verweij; J A van Mourik; P G de Groot
Journal:  J Cell Physiol       Date:  1987-10       Impact factor: 6.384

View more
  6 in total

Review 1.  Nonviral gene transfer strategies for the vasculature.

Authors:  Jennifer L Young; David A Dean
Journal:  Microcirculation       Date:  2002-01       Impact factor: 2.628

Review 2.  Molecular and cellular biology of von Willebrand factor.

Authors:  Cécile V Denis
Journal:  Int J Hematol       Date:  2002-01       Impact factor: 2.490

3.  Functional characterization of a 13-bp deletion (c.-1522_-1510del13) in the promoter of the von Willebrand factor gene in type 1 von Willebrand disease.

Authors:  Maha Othman; Yvette Chirinian; Christine Brown; Colleen Notley; Nicholas Hickson; Daniel Hampshire; Suzanne Buckley; Simon Waddington; Alan L Parker; Andrew Baker; Paula James; David Lillicrap
Journal:  Blood       Date:  2010-08-09       Impact factor: 22.113

4.  Function of von Willebrand factor after crossed bone marrow transplantation between normal and von Willebrand disease pigs: effect on arterial thrombosis in chimeras.

Authors:  T C Nichols; C M Samama; D A Bellinger; J Roussi; R L Reddick; M Bonneau; M S Read; O Bailliart; G G Koch; M Vaiman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

5.  Human von Willebrand factor gene sequences target expression to a subpopulation of endothelial cells in transgenic mice.

Authors:  W C Aird; N Jahroudi; H Weiler-Guettler; H B Rayburn; R D Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

6.  Endothelial-cell-specific regulation of von Willebrand factor gene expression.

Authors:  N Jahroudi; D C Lynch
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.